A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Celgene
New York Medical College
Masonic Cancer Center, University of Minnesota
xCures
Medical University of Vienna
Sanguine Biosciences
University of Milano Bicocca
Istanbul University
Celgene
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
New York Medical College